OR WAIT null SECS
© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Bethesda, MD-Sucampo Pharmaceuticals Inc. has won the exclusive right to license Fujisawa's tacrolimus for ophthalmic use in the United States, Europe, and much of the world.